Lucy Shapiro
CIK 1435944 · last filed 2025-06-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.9K
Companies
3
Total Filings
53
Lifetime Open-Market Net
-$17.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-17 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-05 | GPRO | Grant (A) | +55 | $3.2K | EDGAR |
| 2011-10-05 | GPRO | Grant (A) | +240 | $13.2K | EDGAR |
| 2011-07-06 | GPRO | Grant (A) | +46 | $3.2K | EDGAR |
| 2011-05-26 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-23 | GPRO | Grant (A) | — | $0 | EDGAR |
| 2011-04-05 | GPRO | Grant (A) | +49 | $3.2K | EDGAR |
| 2011-04-04 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-05 | GPRO | Grant (A) | +54 | $3.2K | EDGAR |
| 2010-12-01 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Conv (C) | +44,832 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.